Laurie Goodyear

Laurie Goodyear, MD, PhD

Novel Mechanisms Mediating the Benefits of Exercise of Metabolic Health.

Dr. Laurie Goodyear leads cutting-edge research at the Joslin Diabetes Center (JDC) and Harvard Medical School (HMS), focusing on exercise physiology, diabetes, and metabolic health. As Co-Head of the Section of Integrative Physiology and Metabolism at JDC and Professor of Medicine at HMS, she directs both the Animal Physiology Core Laboratory and the Human Exercise Physiology Laboratory. Her primary goal is to uncover the molecular mechanisms by which exercise enhances health, particularly in metabolic diseases like diabetes and obesity.
Dr. Goodyear’s research has uncovered key insights, including the role of AMP-activated protein kinase (AMPK) in glucose transport and metabolic signaling induced by exercise, as well as the profound effects of exercise on adipose tissue biology and the release of beneficial adipokines. Supported by NIH R01 awards, her work spans from basic mechanistic studies in animals to translational research aimed at developing therapies for metabolic disease.
Beyond her research, Dr. Goodyear plays a pivotal role in numerous administrative capacities at JDC and HMS, including leadership roles and service on committees. She has mentored over 100 individuals, fostering their careers in research and academia globally. Committed to advancing human health through scientific discovery, she continues to drive research from bench to bedside, exploring novel molecules and exercise strategies that optimize health outcomes.